[1]  Himmel H M, Glossmann H,  Ravens U. Naftopidil a new a-adrenoceptor blocking agent with calcium antagonistic properties: characterization of calcium antagonistic effects[J]. J Cardiovasc Pharm, 1991, 17(2):  213-221.

[2]  Ikunobu M, Kyozo Y, Shigeru K. Pharmacological profile on the novel a-adrenoceptor antagonist KT-611 (naftopidil) [J]. Jpn  J Pharmacol,  1991, 55(3): 391-398.

[3]  Bernhard K, Jurgen E, Ilona F, et al.  Synthesis of potential naftopidil metabolites[J]. Arch Pharm, 1993, 326(10):  803-806.

[4]  Stefano C, Giovannella S, Rosano F, et al. Synthesis of compounds with a possible calcium-antagonist and β-blocking activity[J]. Arch Pharm, 1988, 321(10): 731-734.

[5]  Wang Shao-jie (王绍杰),  Sun Dian-chun (孙殿春),  Wang Song-qing (王松青). Synthesis of Naftopidil (萘哌地尔的合成)[J]. Journal of shenyang pharmaceutical university(沈阳药学杂志), 2001, 18(1): 16-18.

[6]  Herbert  M. Naftopidil, A Novel Antihypertensive Drug[J]. Cardiovasc Drug Rev 1994, 12(1): 32-39.

[7]   Zhao Tian-zeng (赵天增). Interpretation of carbon-13 NMR spectra (核磁共振碳谱)[M]. Zhengzhou(郑州): Henan Science & Technology press(河南科学技术出版社）, 1993. P107.

[8]  Ning Yong-cheng(宁永成). Structural Identification of Organic Compounds and Organic Spectroscopy(有机化合物结构鉴定与有机波谱学 第二版)[M]. Beijing（北京）:  Science press（科学出版社）, 2001. P111.